Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-033727
Filing Date
2021-08-19
Accepted
2021-08-19 21:15:02
Documents
2
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1612
2 EX-24 DOCUMENT attachment1.htm EX-24 3975
  Complete submission text file 0000899243-21-033727.txt   6953
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Guyer William (Reporting) CIK: 0001879013 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 211191571